Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome | Zendy

Denusa Wiltgen | Zendy; Igor Gorski Benedetto | Zendy; Lívia Silveira Mastella | Zendy; Poli Mara Spritzer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome

Author(s) -

Denusa Wiltgen,

Igor Gorski Benedetto,

Lívia Silveira Mastella,

Poli Mara Spritzer

Publication year - 2009

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dep072

Subject(s) - polycystic ovary , medicine , insulin resistance , waist , body mass index , endocrinology , quantitative insulin sensitivity check index , risk factor , lipid profile , metabolic syndrome , cholesterol , obesity , insulin sensitivity

Metabolic disturbances are common features of polycystic ovary syndrome (PCOS), which possibly enhance the risk of cardiovascular disease. The aim of this study was to assess the accuracy of lipid accumulation product (LAP) index as a marker of cardiovascular risk in PCOS patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research